These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
703 related articles for article (PubMed ID: 27141426)
1. Nanoparticle transport across the blood brain barrier. Grabrucker AM; Ruozi B; Belletti D; Pederzoli F; Forni F; Vandelli MA; Tosi G Tissue Barriers; 2016; 4(1):e1153568. PubMed ID: 27141426 [TBL] [Abstract][Full Text] [Related]
2. Targeting central nervous system pathologies with nanomedicines. Mizrahy S; Gutkin A; Decuzzi P; Peer D J Drug Target; 2019; 27(5-6):542-554. PubMed ID: 30296187 [TBL] [Abstract][Full Text] [Related]
3. Nanomedicines for the Treatment of CNS Diseases. Reynolds JL; Mahato RI J Neuroimmune Pharmacol; 2017 Mar; 12(1):1-5. PubMed ID: 28150132 [TBL] [Abstract][Full Text] [Related]
4. Current Strategies for Brain Drug Delivery. Dong X Theranostics; 2018; 8(6):1481-1493. PubMed ID: 29556336 [TBL] [Abstract][Full Text] [Related]
5. Drug delivery across the blood-brain barrier: recent advances in the use of nanocarriers. Mulvihill JJ; Cunnane EM; Ross AM; Duskey JT; Tosi G; Grabrucker AM Nanomedicine (Lond); 2020 Jan; 15(2):205-214. PubMed ID: 31916480 [TBL] [Abstract][Full Text] [Related]
6. Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases. Teixeira MI; Lopes CM; Amaral MH; Costa PC Eur J Pharm Biopharm; 2020 Apr; 149():192-217. PubMed ID: 31982574 [TBL] [Abstract][Full Text] [Related]
7. Concepts, technologies, and practices for drug delivery past the blood-brain barrier to the central nervous system. Crawford L; Rosch J; Putnam D J Control Release; 2016 Oct; 240():251-266. PubMed ID: 26724368 [TBL] [Abstract][Full Text] [Related]
8. The role of non-endothelial cells on the penetration of nanoparticles through the blood brain barrier. Moura RP; Almeida A; Sarmento B Prog Neurobiol; 2017 Dec; 159():39-49. PubMed ID: 28899762 [TBL] [Abstract][Full Text] [Related]
9. Strategies for transporting nanoparticles across the blood-brain barrier. Zhang TT; Li W; Meng G; Wang P; Liao W Biomater Sci; 2016 Feb; 4(2):219-29. PubMed ID: 26646694 [TBL] [Abstract][Full Text] [Related]
10. Differential receptor-mediated drug targeting to the diseased brain. Rip J; Schenk GJ; de Boer AG Expert Opin Drug Deliv; 2009 Mar; 6(3):227-37. PubMed ID: 19327042 [TBL] [Abstract][Full Text] [Related]
11. Nanotechnologies: a strategy to overcome blood-brain barrier. De Rosa G; Salzano G; Caraglia M; Abbruzzese A Curr Drug Metab; 2012 Jan; 13(1):61-9. PubMed ID: 22292810 [TBL] [Abstract][Full Text] [Related]
12. Nano carriers for drug transport across the blood-brain barrier. Li X; Tsibouklis J; Weng T; Zhang B; Yin G; Feng G; Cui Y; Savina IN; Mikhalovska LI; Sandeman SR; Howel CA; Mikhalovsky SV J Drug Target; 2017 Jan; 25(1):17-28. PubMed ID: 27126681 [TBL] [Abstract][Full Text] [Related]
13. Crossing the Blood-Brain Barrier: Recent Advances in Drug Delivery to the Brain. Patel MM; Patel BM CNS Drugs; 2017 Feb; 31(2):109-133. PubMed ID: 28101766 [TBL] [Abstract][Full Text] [Related]
14. Noninvasive nanoparticle strategies for brain tumor targeting. Sun C; Ding Y; Zhou L; Shi D; Sun L; Webster TJ; Shen Y Nanomedicine; 2017 Nov; 13(8):2605-2621. PubMed ID: 28756093 [TBL] [Abstract][Full Text] [Related]
15. Transport of drugs across the blood-brain barrier by nanoparticles. Wohlfart S; Gelperina S; Kreuter J J Control Release; 2012 Jul; 161(2):264-73. PubMed ID: 21872624 [TBL] [Abstract][Full Text] [Related]
16. Nanoparticle- and liposome-carried drugs: new strategies for active targeting and drug delivery across blood-brain barrier. Pinzón-Daza ML; Campia I; Kopecka J; Garzón R; Ghigo D; Riganti C Curr Drug Metab; 2013 Jul; 14(6):625-40. PubMed ID: 23869808 [TBL] [Abstract][Full Text] [Related]
17. Cellular and Molecular Targeted Drug Delivery in Central Nervous System Cancers: Advances in Targeting Strategies. Zhao X; Ye Y; Ge S; Sun P; Yu P Curr Top Med Chem; 2020; 20(30):2762-2776. PubMed ID: 32851962 [TBL] [Abstract][Full Text] [Related]
18. The blood-brain barrier: clinical implications for drug delivery to the brain. De Boer AG; Breimer DD J R Coll Physicians Lond; 1994; 28(6):502-6. PubMed ID: 7884704 [TBL] [Abstract][Full Text] [Related]
19. Nano-enabled delivery systems across the blood-brain barrier. Hwang SR; Kim K Arch Pharm Res; 2014 Jan; 37(1):24-30. PubMed ID: 24170511 [TBL] [Abstract][Full Text] [Related]
20. Nanoparticle delivery to the brain--By focused ultrasound and self-assembled nanoparticle-stabilized microbubbles. Åslund AKO; Berg S; Hak S; Mørch Ý; Torp SH; Sandvig A; Widerøe M; Hansen R; de Lange Davies C J Control Release; 2015 Dec; 220(Pt A):287-294. PubMed ID: 26518721 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]